A Prospective Randomized Masked Placebo‐Controlled Clinical Study of Capromorelin in Dogs with Reduced Appetite

机译：Capromorelin在食欲不振犬中的一项前瞻性随机掩盖安慰剂对照临床研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundReduced appetite is a common clinical sign in dogs. This study evaluated the effectiveness and safety of capromorelin oral solution, (ENTYCE^®, Aratana Therapeutics, Leawood, KS) a new drug that is a ghrelin receptor agonist, for stimulation of appetite in dogs with reduced appetite.

机译：背景食欲不振是犬的常见临床体征。这项研究评估了己糖莫林口服溶液（ENTYCE ^{®，Aratana Therapeutics，Leawood，KS）的一种新药，该药物是生长素释放肽受体激动剂，可刺激食欲不振的狗的食欲。}

著录项

期刊名称 Journal of Veterinary Internal Medicine
作者
B. Zollers; J.A. Wofford; E. Heinen; M. Huebner; L. Rhodes;
展开▼
作者单位

展开▼
年(卷),期 2016(30),6
年度 2016
页码 1851–1857
总页数 7
原文格式 PDF
正文语种
中图分类动物医学（兽医学）;
关键词
Appetite stimulation Food consumption Ghrelin receptor agonist Growth hormone secretagogue Inappetence;

机译：食欲刺激;食物消耗;Ghrelin受体激动剂;生长激素促分泌素;食欲不振;

相似文献

外文文献
中文文献
专利

1. A Prospective, Randomized, Masked, Placebo‐Controlled Clinical Study of Capromorelin in Dogs with Reduced Appetite [J] . Zollers B., Wofford J.A., Heinen E., Journal of Veterinary Internal Medicine . 2016,第6期

机译：Capromorelin在食欲不振犬中的一项前瞻性，随机，掩盖，安慰剂对照临床研究
2. Capromorelin oral solution (ENTYCE?) increases food consumption and body weight when administered for 4 consecutive days to healthy adult Beagle dogs in a randomized, masked, placebo controlled study [J] . Bill Zollers, Linda Rhodes, Ernst Heinen BMC Veterinary Research . 2017,第1期

机译：在一项随机，掩盖，安慰剂对照的健康成年Beagle犬中连续服用4天后，Capromorelin口服溶液（ENTYCE？）会增加食物消耗和体重
3. A Prospective, Randomized, Masked, Placebo‐Controlled Multisite Clinical Study of Grapiprant, an EP4 Prostaglandin Receptor Antagonist (PRA), in Dogs with Osteoarthritis [J] . Rausch‐Derra L., Huebner M., Wofford J., Journal of Veterinary Internal Medicine . 2016,第3期

机译：Grapiprant，一种EP4前列腺素受体拮抗剂（PRA），在骨关节炎狗中进行的前瞻性，随机，蒙面，安慰剂对照多点临床研究
4. MULTI-CENTER, PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED STUDY OF ORAL TOCERANIB PHOSPHATE (PALLADIATM, SU11654), A RECEPTOR TYROSINE KINASE INHIBITOR, FOR THE TREATMENT OF DOGS WITH RECURRENT MAS [C] . Cheryl L London, Carolyn J Henry, Anthony W Rusk, Annual conference of the Veterinary Cancer Society . 2008

机译：多中心，安慰剂对照，双盲，随机研究口服Toceranib磷酸盐（Palladia TM，SU11654），受体酪氨酸激酶抑制剂，用于治疗经常性MAS的狗
5. Efficacy of the Chinese herbal formula CUF2 in the treatment of childhood asthma: Animal experiment, in vitro study and randomized, double-blinded, placebo-controlled clinical trial. [D] . Wong, Yeuk Oi. 2006

机译：中药配方CUF2在治疗儿童哮喘中的功效：动物实验，体外研究以及随机，双盲，安慰剂对照的临床试验。
6. A Prospective Randomized Masked Placebo‐Controlled Multisite Clinical Study of Grapiprant an EP4 Prostaglandin Receptor Antagonist (PRA) in Dogs with Osteoarthritis [O] . L. Rausch‐Derra, M. Huebner, J. Wofford, 2016

机译：Grapiprant（一种EP4前列腺素受体拮抗剂（PRA））在骨关节炎犬中的前瞻性随机掩蔽安慰剂对照多点临床研究
7. Capromorelin oral solution (ENTYCE®) increases food consumption and body weight when administered for 4 consecutive days to healthy adult Beagle dogs in a randomized, masked, placebo controlled study [O] . 2017

机译：在一项随机，掩盖，安慰剂对照的健康成年Beagle犬中连续服用4天后，Capromorelin口服溶液（ENTYCE®）可增加食物消耗和体重

A Prospective Randomized Masked Placebo‐Controlled Clinical Study of Capromorelin in Dogs with Reduced Appetite

摘要

著录项

相似文献

相关主题

期刊订阅